Numerate: Numerate Receives $2M SBIR Phase II Award

Numerate, Inc., a San Bruno, CA-based computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, received a $2m Small Business Innovation Research (SBIR) Phase II grant. The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) provided the award to Numerate, following [...]The post Numerate Receives $2M SBIR Phase II Award appeared first on FinSMEs.